Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0309187 on July 29, 2009

Published online before print July 29, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
jlb.0309187v1
86/5/1239    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Paiva, C. N.
Right arrow Articles by Bozza, M. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paiva, C. N.
Right arrow Articles by Bozza, M. T.
(Journal of Leukocyte Biology. 2009;86:1239-1246.)
© 2009 Society for Leukocyte Biology

CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection

Cláudia N. Paiva*,1, Rodrigo T. Figueiredo*, Karina Kroll-Palhares{dagger}, Andrea A. Silva{dagger}, Jaline C. Silvério{dagger}, Daniel Gibaldi*,{dagger}, Alexandre dos S. Pyrrho{ddagger}, Claudia F. Benjamim§, Joseli Lannes-Vieira{dagger} and Marcelo T. Bozza*,1

Departamentos de
* Imunologia, Instituto de Microbiologia Prof Paulo de Góes,
{ddagger} Análises Clínicas e Toxicológicas, Faculdade de Farmácia, and
§ Farmacologia Básica e Clinica, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Brazil; and
{dagger} Laboratório de Pesquisa em Auto-imunidade e Imuno-regulação, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil

1. Correspondence: Departamento de Imunologia, Instituto de Microbiologia Prof Paulo de Góes, UFRJ, Av. Carlos Chagas Filho 373, CCS Bloco I, Ilha do Fundão, Rio de Janeiro, RJ, Brazil, 21941-902. E-mail: cnpaiva{at}iname.com; mbozza{at}micro.ufrj.br

ABSTRACT

CCL2/MCP-1 has emerged recently as a critical factor in infectious and autoimmune myocarditis. In fact, this chemokine is produced in great amounts in hearts from Trypanosoma cruzi-infected mice and is known to enhance parasite uptake and destruction by macrophages. Herein, we studied the involvement of CCL2 in tissue inflammation and resistance to T. cruzi. Infected CCL2–/– mice developed higher parasitemias and died earlier than WT mice. Close to their death, T. cruzi-infected CCL2–/– presented greater amounts of TNF, IFN-{gamma}, and IL-10 in plasma than WTs and clinical signs of systemic inflammatory response. Amastigote nests were more frequent in hearts and livers from infected CCL2–/– tissues than in WTs, and reduced numbers of leukocytes infiltrated their tissues. Leukocytes formed diffuse but not focal infiltrates in hearts from infected CCL2–/– mice, and perivascular cuffs could still be found in their livers. Infected CCL2–/– mice had smaller percentages of activated CD11b (Mac-1)+CD107b (Mac-3)+ macrophages and CD8+CD69hi cells among heart and liver infiltrates than WTs (flow cytometry), indicating that CCL2 controls subset migration/activation. CCL2 accumulated among focal heart infiltrates, suggesting that this chemokine is involved in retention of mononuclear cells in particular spots. Peritoneal macrophages from CCL2–/– mice displayed decreased trypanocidal activity. Our results demonstrate that CCL2 contributes to reduce parasite growth and indicate that it does so by controlling the distribution, cellular composition, and state of activation of inflammatory infiltrates in acute T. cruzi infection.

Key Words: heart • liver • myocarditis • flow cytometry • recruitment • CD8 • monocytes • Chagas’ disease